secwatch.observer — SEC 8-K summary
======================================

Issuer:     HYPERION DEFI, INC. (HYPD)
CIK:        0001682639
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0001104659-25-050528
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Eyenovia Reports Q1 2025 Financial Results, Provides Merger and Optejet Development Update
--------------------------------------------------------------------------------

- Net loss narrowed to $3.5 million ($1.59 per share) versus $10.9 million ($18.75 per share) in Q1 2024.
- Continuing merger negotiations with Betaliq; binding exclusivity extended to June 7, 2025.
- Optejet user-filled device on track to file for FDA device approval in September 2025.
- Cash burn reduced by approximately 70% versus prior year; debt restructuring with Avenue Capital defers payments to October 2025.
- Unrestricted cash and equivalents totaled $3.9 million as of March 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682639/000110465925050528/0001104659-25-050528-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682639/000110465925050528/tm2515543d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-050528

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer